Standard Biotools Inc. (LAB)
NASDAQ · Healthcare
Standard Biotools Inc. annual/quarterly long term debt history from 2010 to 2024. Long term debt refers to financial obligations that are due more than one year in the future.
- Standard Biotools Inc. long term debt for the quarter ending December 31, 2024 were 299,000, a 99.53% decrease year-over-year.
- Standard Biotools Inc. long term debt for 2024 were 299,000, a 99.53% decrease from 2023.
- Standard Biotools Inc. long term debt for 2023 were 63.5M, a 2.13% decrease from 2022.
- Standard Biotools Inc. long term debt for 2022 were 64.9M, a 66.76% decrease from 2017.
- Standard Biotools Inc. long term debt for 2017 were 195.2M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Standard Biotools Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2024 | $0 |
| 2023 | $64 |
| 2022 | $65 |
| 2017 | $195 |
| 2011 | $1 |
| 2010 | $10 |
| Standard Biotools Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2024-12-31 | $0 |
| 2023-12-31 | $64 |
| 2022-12-31 | $65 |
| 2017-12-31 | $195 |
| 2011-12-31 | $1 |
| 2010-12-31 | $10 |
Standard Biotools Inc. Long Term Debt — FAQ
Standard Biotools Inc. (LAB) long term debt over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LAB's long term debt history?
The chart and table above show Standard Biotools Inc.'s long term debt by year and by quarter, including the growth rate.